These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6701397)

  • 1. Circulating dopamine levels and a protective action of naloxone in canine splanchnic arterial occlusion shock.
    Eddy LJ; Joiner DW; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):113-25. PubMed ID: 6701397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late administration of methylprednisolone does not enhance naloxone effect in hypovolemic shock.
    Beamer KC; Daly T; Vargish T
    Circ Shock; 1986; 19(2):221-30. PubMed ID: 3719922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of naloxone in early canine hypovolemic shock.
    Vargish T; Beamer K
    Circ Shock; 1985; 17(1):45-57. PubMed ID: 2996802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone requires circulating catecholamines to attenuate the cardiovascular suppression of endotoxic shock.
    Allgood SC; Gurll NJ; Reynolds DG
    J Surg Res; 1988 Jan; 44(1):73-81. PubMed ID: 3336212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression of left ventricular performance during canine splanchnic artery occlusion shock.
    Nightingale LM; Tambolini WP; Kish P; Weber P; Goldfarb RD
    Circ Shock; 1984; 14(2):93-106. PubMed ID: 6509727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of temperature on naloxone treatment in canine hemorrhagic shock.
    Horton JW; Tuggle DW; Kiser RS
    Circ Shock; 1984; 14(4):251-65. PubMed ID: 6096039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of naloxone on hemorrhagic shock in the beagle.
    Toth PD; Hamburger SA; Judy WV
    Circ Shock; 1986; 20(1):35-42. PubMed ID: 3769144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone reversal of hypovolemic shock in dogs.
    Vargish T; Reynolds DG; Gurll NJ; Lechner RB; Holaday JW; Faden AI
    Circ Shock; 1980; 7(1):31-8. PubMed ID: 6248264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock.
    Gurll NJ; Vargish T; Reynolds DG; Lechner RB
    Surgery; 1981 Mar; 89(3):364-9. PubMed ID: 6258256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock.
    Dziki AJ; Lynch WH; Ramsey CB; Law WR
    Circ Shock; 1993 Jan; 39(1):29-38. PubMed ID: 8386986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of atrial natriuretic factor and catecholamines in endotoxin shock in dogs.
    Gullichsen E; Nelimarkka O; Scheinin M; Antila K; Leppäluoto J; Niinikoski J
    Acta Chir Scand; 1989; 155(11-12):567-71. PubMed ID: 2533442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic shock.
    Lechner RB; Gurll NJ; Reynolds DG
    Circ Shock; 1985; 16(4):347-61. PubMed ID: 3836027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system is involved in the cardiovascular responses to naloxone in canine endotoxic but not hemorrhagic shock.
    Gurll NJ; Ganes E; Reynolds DG
    Circ Shock; 1987; 22(2):115-25. PubMed ID: 3594733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased inotropic state during splanchnic artery occlusion shock in the dog.
    Kober PM; Gibbons DA; Raymond RM
    Circ Shock; 1987; 21(2):97-110. PubMed ID: 3829331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
    De Backer D; Creteur J; Silva E; Vincent JL
    Crit Care Med; 2003 Jun; 31(6):1659-67. PubMed ID: 12794401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.
    McIntosh TK; Palter M; Grasberger R; Vezina R; Yeston NS; Egdahl RH
    Circ Shock; 1985; 17(4):313-25. PubMed ID: 4092345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma catecholamine levels in porcine Escherichia coli septicaemia and following treatment with buprenorphine or naloxone.
    Donaldson MD; Vesey CJ; Bouloux PM; Watson JD; Besser GM; Hinds CJ
    Circ Shock; 1993 Mar; 39(3):169-77. PubMed ID: 8453740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naloxone in treating hemorrhagic shock in dogs with maintained baroreceptor responsiveness.
    Wagner-Mann CC; Gross DR
    Am J Vet Res; 1986 Aug; 47(8):1763-6. PubMed ID: 3752687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock.
    Oei HH; Zoganas HC; Sakane Y; Robson RD; Glenn TM
    Circ Shock; 1986; 18(2):95-106. PubMed ID: 3753907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.